<code id='10FB81BB93'></code><style id='10FB81BB93'></style>
    • <acronym id='10FB81BB93'></acronym>
      <center id='10FB81BB93'><center id='10FB81BB93'><tfoot id='10FB81BB93'></tfoot></center><abbr id='10FB81BB93'><dir id='10FB81BB93'><tfoot id='10FB81BB93'></tfoot><noframes id='10FB81BB93'>

    • <optgroup id='10FB81BB93'><strike id='10FB81BB93'><sup id='10FB81BB93'></sup></strike><code id='10FB81BB93'></code></optgroup>
        1. <b id='10FB81BB93'><label id='10FB81BB93'><select id='10FB81BB93'><dt id='10FB81BB93'><span id='10FB81BB93'></span></dt></select></label></b><u id='10FB81BB93'></u>
          <i id='10FB81BB93'><strike id='10FB81BB93'><tt id='10FB81BB93'><pre id='10FB81BB93'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:12956
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more
          Private equity deals in Medicare Advantage declines
          Private equity deals in Medicare Advantage declines

          AdobeMajorinsurancecompanieslikeUnitedHealthcareandHumanahaveedgedoutprivateequityfirmsfrominvesting

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Readout LOUD podcast: How biotech is using artificial intelligence

          HasAIreallysolvedbiology?Whatcanmachinesteachusaboutmedicine?Andwhat’sadigitaltwin?Wecoverallthatand